INSIGHTS ON SOLID DOSE MANUFACTURING
-
Developing And Manufacturing Drugs With HPAPIs
Learn why companies must invest in specialized expertise to develop scalable, safe, and efficient manufacturing processes for highly potent oral solid dose products.
-
Segments: Next-Generation Tablet Press Technology
Segments increase press output by up to 25% and cut setup time by 88%. Learn the benefits, drawbacks, and manufacturing needs of this rapidly growing tablet press technology.
-
Zhunan Facility Site VR Tour
Bora’s 36,000-square-meter Zhunan, Taiwan facility delivers flexible, high-quality cGMP oral solid dose manufacturing with access to major markets including North America and the EU.
-
The Future Of Oral Solid Dose Development And Innovation
Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.
-
HPAPIS Production: "Where Micrograms Matters"4/13/2026
In HPAPI manufacturing, micrograms make a difference. Risk‑based containment, smart facility design, and exposure limits safeguard people, product, and performance.
-
Combining Powdose® And Diffucaps® For Precise Solid Oral Dosing6/30/2025
Combining POWDOSE® and Diffucaps® enables precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.
-
Pharmaceutical X-Ray Counts Capsules And Pills8/15/2025
See how advanced x-ray inspection technology verifies correct pill count, identifies broken capsules, and detects foreign contaminants in pharmaceutical sachet packets.
-
The Importance Of Polymorph Screenings5/6/2026
Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.
-
High Potency APIs And The Evolving Demands Of Drug Development4/13/2026
See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.
SOLID DOSE MANUFACTURING SOLUTIONS
-
Used K-Tron powder delumper hopper, stainless steel construction, with .5 hp, 230/460 volt motor drive with VFD controllers.
-
Used GlobePharma Single Station Tablet Press.
-
Using single-use technologies to achieve continuous manufacturing has long been a goal of biomanufacturers. At ILC Dover, we have focused on developing premier films for a wide array of powder handling and containment needs. As a result, our engineers have created cutting-edge films designed to provide unmatched performance characteristics, while increasing handling speed and safety.
-
Natoli organization is a reputed leader with more than a half century experience in the tablet manufacturing technology.
We understand tablets better. We are here for serving your needs to overcome challenges associated with commercial manufacturing of solid dosage forms across the globe (North America, Europe, Asia).
Our Natoli scientific team uses holistic approach to understand and solve important tableting problems like capping, lamination, picking, and sticking. We integrate scientific information gathered at material, process, and instrument level to understanding and decode root causes of these common tableting issues.
-
Used Elizabeth Hata R&D tablet press, model EP200, B/D tooled with 10 station turret, 5 stations each B and D, 16 mm B, 22 mm D max tablet diameter, 17 mm B, 18 mm D max depth of fill, rated up to 6000 tablets/hour, with feed hoppers and feed frames, Machine #81, built 2011.